See All Slides - tctmd.com

Slides

Presentation TCT 2012

Late Breaking Clinical Trials: Venous Thromboembolic Disease EINSTEIN-PE (Rivaroxaban)

Presenter: Jeffrey Kuvin

October 23, 2012

Presentation TCT 2012

Do Statins and Other Therapies Alter Vulnerable Plaque Characteristics? Insights from Imaging

Presenter: Pedro Moreno

October 23, 2012

Presentation TCT 2012

Nanoparticle-based Therapies for Atherosclerosis: The NANOM FIM Study

Presenter: Alexander Kharlamov

October 23, 2012

Presentation TCT 2012

TCT-9. Morphological Assessment of Renal Arteries After Radiofrequency Catheter-based Sympathetic Denervation in a Porcine Model

Presenter: Michael Joner

October 23, 2012

Presentation TCT 2012

Viability Testing, Clinical Decision Making(2)

Presenter: Issam Mikati

October 23, 2012

Presentation TCT 2012

TCT-101. 12-month Results of a 2nd Generation Transapical Aortic Bioprosthesis for the Treatment of Patients with Severe Aortic Stenosis

Presenter: Joerg Kempfert

October 23, 2012

Presentation TCT 2012

Background Medical and Device Therapies for Patients with VADs

Presenter: Emma Birks

October 23, 2012

Presentation TCT 2012

ELM Presentation(8)

Presenter: Paul Sorajja

October 23, 2012

Presentation TCT 2012

TCT-104. Feasibility Study of the Repositionable Lotus Aortic Valve Replacement System: 3-Month Outcomes in 11 Patients at High Surgical Risk (REPRISE I)

Presenter: Ian Meredith

October 23, 2012

Presentation TCT 2012

Late Breaking Clinical Trials: BRIDGE-ACS (Multimodality Approach to Adherence), INFUSE-AMI (STEMI), and IMMEDIATE (GIK)

Presenter: Ajay Kirtane

October 23, 2012

Advertisement

Slides

Late Breaking Clinical Trials: Venous Thromboembolic Disease EINSTEIN-PE (Rivaroxaban)

Do Statins and Other Therapies Alter Vulnerable Plaque Characteristics? Insights from Imaging

Nanoparticle-based Therapies for Atherosclerosis: The NANOM FIM Study

TCT-9. Morphological Assessment of Renal Arteries After Radiofrequency Catheter-based Sympathetic Denervation in a Porcine Model

Viability Testing, Clinical Decision Making(2)

TCT-101. 12-month Results of a 2nd Generation Transapical Aortic Bioprosthesis for the Treatment of Patients with Severe Aortic Stenosis

Background Medical and Device Therapies for Patients with VADs

ELM Presentation(8)

TCT-104. Feasibility Study of the Repositionable Lotus Aortic Valve Replacement System: 3-Month Outcomes in 11 Patients at High Surgical Risk (REPRISE I)

Late Breaking Clinical Trials: BRIDGE-ACS (Multimodality Approach to Adherence), INFUSE-AMI (STEMI), and IMMEDIATE (GIK)

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content